Skip to main content

Day: September 17, 2025

STMicroelectronics to advance next-generation chip manufacturing technology with new PLP pilot line in Tours, France

PR N°C3358C STMicroelectronics to advance next-generation chip manufacturing technology with new PLP pilot line in Tours, FranceMulti-disciplinary team to further develop innovative approach to chip packaging and test manufacturing technology boosting efficiency and flexibility Part of ST’s strategic initiative on heterogeneous integration, contributing to technology roadmap on RF, analog, power and digital products Launch of the PLP pilot line in Tours supported by $60 million investment and synergies with local R&D ecosystemGeneva, Switzerland, September 17, 2025 — STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, today announced new details regarding the development of the next generations of Panel-Level Packaging (PLP) technology through...

Continue reading

IDEX Biometrics ASA secures 45,000 sensor system order as DigAware accelerates nationwide rollout

IDEX Biometrics has landed an order of 45,000 from DigAware, the innovative product division of Emnovate, completing the sensor delivery pipeline announced January 8, 2025. This milestone order positions DigAware to rapidly scale their breakthrough biometric access solutions across America before expanding globally. Robin Bienfait, CEO and Founder of DigAware commented: “Our investment in this market is driven by the rapidly growing demand for secure access control and improve safety within our target markets. Throughout the development process, we have been impressed by the speed and accuracy of the IDEX sensor and biometric matching software, as well as the outstanding support from the IDEX team.” Anders Storbråten, CEO of IDEX, highlighted the strategic significance: “DigAware exemplifies our ideal high-growth partner. It is encouraging...

Continue reading

Q1 2025 Dividend Exchange Rate

Q1 2025 Dividend Exchange Rate   Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) announced on May 12, 2025 a dividend in respect of the first quarter ended March 31, 2025 in the amount of 29 cents per share (the “Q1 2025 Dividend”.)  The Company will pay the Q1 2025 Dividend on September 30, 2025, to those shareholders on the register on August 29, 2025.  The Company announces that shareholders who have elected to receive their dividends in GBP sterling will receive an equivalent dividend payment of 21.321 pence per share, based on the September 12, 2025 exchange rate of GBP 0.73520=US $1.00. For further information, please contact:Diversified Energy Company PLC +1 973 856 2757Doug Kris dkris@dgoc.comSenior Vice President, Investor Relations & Corporate Communications www.div.energy   FTI Consulting dec@fticonsulting.comU.S....

Continue reading

BW Energy announces changes to the Executive Management team

BW Energy announces changes to the Executive Management team BW Energy appoints Brice Morlot as Chief Operating Officer and Thomas Young as Chief Financial Officer. Mr. Morlot joined BW Energy in 2024 as the Company’s CFO. He has extensive experience, combining financial expertise and a strong operational background in the E&P sector. Mr. Morlot succeeds Lin Espey, who stepped down as COO in July. Mr. Young, previously the Chief Strategy Officer, has been part of the company since inception and overseen the development of BW Energy’s growth strategy. He has played a key role in the company’s financing activities, leveraging a wide range of strategy, economics and corporate finance competencies. “The appointments reflect our strategy to promote from within and build on existing strengths. Brice and Thomas have contributed significantly...

Continue reading

Sampo plc’s share buybacks 16 September 2025

Sampo plc, stock exchange release, 17 September 2025 at 8:30 am EEST Sampo plc’s share buybacks 16 September 2025                                                  On 16 September 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  4,114 9.78 AQEU    163,413 9.78 CEUX  41,102 9.79 TQEX  179,068 9.78 XHELTOTAL 387,697 9.78  * rounded to two decimals                      On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation...

Continue reading

H1 2025 Trading Update: EBITDA Up 15% YoY. Strong Results, Better Outlook

Prague, 17 September 2025 GEVORKYAN H1 2025 Highlights:Revenues increased by 11% YoY to over EUR 42.1 million EBITDA grew by 15% YoY, reaching EUR 13.8 million EBITDA margin 1.2 p.p. up, representing 32.7% FY2025 outlook: Estimated revenue growth of 11–18%, EBITDA growth of 15–23% 5-year outlook: Estimated revenue CAGR of 10–16%, EBITDA CAGR of 10–18%GEVORKYAN, a.s., a world-renowned leading innovator in powder metallurgy, announces selected financial and operating results for the six months ending June 30, 2025, updated FY 2025 and five-year outlook. GEVORKYAN, a.s. reported H1 2025 revenues of EUR 42.2 million, an increase by 11% YoY, and EBITDA of EUR 13.8 million, a 15% YoY growth, reaching an EBITDA margin of 32.7% (+1.2 p.p. YoY).  The company further reported operating EBIT of EUR 4.6 million in H1 2025, an increase...

Continue reading

TextMagic AS adoption of the resolution without convening a meeting

TextMagic AS (registry code 16211377, hereinafter the “Company”) Management Board announces this draft resolution of the shareholders with the purpose of adopting the resolution of the shareholders without calling a meeting in accordance with clause 2991 of the Commercial Code to distribute profit to the shareholders. In order to optimize costs, the Management Board of the Company has decided to adopt the resolution without convening a meeting and to not organise a general meeting of shareholders. Draft resolution: Distribution of Profit According to the audited annual report of the Company for the financial year 2024, as approved by the shareholders, the distributable profit as of 31 December 2024 amounts to a total of EUR 3,534,000. To distribute profit as follows:To pay a dividend of EUR 0.15 per share, i.e., to distribute...

Continue reading

DEME signs contract to reinforce the Lekdijk in the Netherlands

DEME has signed a contract for reinforcement of the Lekdijk in the Netherlands. For this project, DEME is working together with Heijmans and GMB in the Lekensemble consortium to reinforce the dike between Wijk bij Duurstede and Amerongen (WAM). Commissioned by Hoogheemraadschap De Stichtse Rijnlanden, this vital project is part of the Dutch Flood Protection Program and aims to safeguard hundreds of thousands of residents from high water.AttachmentP2025 DEME Sterke Lekdijk 20250917 ENG

Continue reading

Net asset value of the EfTEN United Property Fund as of 31.08.2025

The net asset value (NAV) of EfTEN United Property Fund units was 11,30 euros at the end of August, up 0,6% month-on-month. The fund earned 166 thousand euros in net profit in August and 2,01 million euros in net profit in the first eight months of 2025 (470 thousand euros in the same period last year). In August, the renovation of a residential rental apartment building in Riga, where the fund is invested through the EfTEN Residential Fund, was completed. As a result, 102 renovated apartments were added to the fund’s portfolio, the letting of which began in early September. Before the building’s final completion, approximately 30% of the rental apartments were already booked. Along with the residential rental building in Riga, the fund’s portfolio includes four residential rental buildings with over 450 apartments in Tallinn,...

Continue reading

Oruka Therapeutics Announces $180 Million Private Placement

MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka” or the “Company”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of approximately $180 million to the Company, before placement agent fees and offering expenses. The PIPE financing was led by Viking Global Investors, and included participation from both new and existing investors, including Affinity Healthcare Fund, Blackstone Multi-Asset Investing, Commodore Capital, Cormorant Asset Management, Deep Track Capital, Fairmount, Great Point Partners,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.